44 related articles for article (PubMed ID: 26208523)
1. The 1,2-Diaminocyclohexane Carrier Ligand in Oxaliplatin Induces p53-Dependent Transcriptional Repression of Factors Involved in Thymidylate Biosynthesis.
Kiyonari S; Iimori M; Matsuoka K; Watanabe S; Morikawa-Ichinose T; Miura D; Niimi S; Saeki H; Tokunaga E; Oki E; Morita M; Kadomatsu K; Maehara Y; Kitao H
Mol Cancer Ther; 2015 Oct; 14(10):2332-42. PubMed ID: 26208523
[TBL] [Abstract][Full Text] [Related]
2. Differential control of dNTP biosynthesis and genome integrity maintenance by the dUTPase superfamily enzymes.
Hirmondo R; Lopata A; Suranyi EV; Vertessy BG; Toth J
Sci Rep; 2017 Jul; 7(1):6043. PubMed ID: 28729658
[TBL] [Abstract][Full Text] [Related]
3. Targeting nucleotide metabolism enhances the efficacy of anthracyclines and anti-metabolites in triple-negative breast cancer.
Davison C; Morelli R; Knowlson C; McKechnie M; Carson R; Stachtea X; McLaughlin KA; Prise VE; Savage K; Wilson RH; Mulligan KA; Wilson PM; Ladner RD; LaBonte MJ
NPJ Breast Cancer; 2021 Apr; 7(1):38. PubMed ID: 33824328
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum to "Overexpression of nucleotide metabolic enzyme DUT in hepatocellular carcinoma potentiates a therapeutic opportunity through targeting its dUTPase activity" [Cancer Lett., 548, (1 November 2022)].
Xu M; Liu Y; Wan HL; Wong AM; Ding X; You W; Lo WS; Ng KK; Wong N
Cancer Lett; 2024 Feb; 583():216601. PubMed ID: 38161138
[No Abstract] [Full Text] [Related]
5. Aflibercept: A Review in Metastatic Colorectal Cancer.
Syed YY; McKeage K
Drugs; 2015 Aug; 75(12):1435-45. PubMed ID: 26220913
[TBL] [Abstract][Full Text] [Related]
6. S-1 and irinotecan with or without bevacizumab versus 5-fluorouracil and leucovorin plus oxaliplatin with or without bevacizumab in metastatic colorectal cancer: a pooled analysis of four phase II studies.
Iwasa S; Nagashima K; Yamaguchi T; Matsumoto H; Ichikawa Y; Goto A; Yasui H; Kato K; Okita NT; Shimada Y; Yamada Y
Cancer Chemother Pharmacol; 2015 Sep; 76(3):605-14. PubMed ID: 26220845
[TBL] [Abstract][Full Text] [Related]
7. GTSE1 expression represses apoptotic signaling and confers cisplatin resistance in gastric cancer cells.
Subhash VV; Tan SH; Tan WL; Yeo MS; Xie C; Wong FY; Kiat ZY; Lim R; Yong WP
BMC Cancer; 2015 Jul; 15():550. PubMed ID: 26209226
[TBL] [Abstract][Full Text] [Related]
8. P53‑microRNA interactions regulate the response of colorectal tumor cells to oxaliplatin under normoxic and hypoxic conditions.
Zhang J; Li C; Sun L; Sun D; Zhao T
Oncol Rep; 2023 Dec; 50(6):. PubMed ID: 37921068
[TBL] [Abstract][Full Text] [Related]
9. DNA Methylation Biomarkers for Prediction of Response to Platinum-Based Chemotherapy: Where Do We Stand?
Tavares NT; Gumauskaitė S; Lobo J; Jerónimo C; Henrique R
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740584
[TBL] [Abstract][Full Text] [Related]
10. Targeting DNA repair pathway in cancer: Mechanisms and clinical application.
Wang M; Chen S; Ao D
MedComm (2020); 2021 Dec; 2(4):654-691. PubMed ID: 34977872
[TBL] [Abstract][Full Text] [Related]
11. Identification and Characterization of a Novel Epitope of ASFV-Encoded dUTPase by Monoclonal Antibodies.
Zhang S; Wang R; Zhu X; Jin J; Lu W; Zhao X; Wan B; Liao Y; Zhao Q; Netherton CL; Zhuang G; Sun A; Zhang G
Viruses; 2021 Oct; 13(11):. PubMed ID: 34834981
[TBL] [Abstract][Full Text] [Related]
12. Redox status of cysteines does not alter functional properties of human dUTPase but the Y54C mutation involved in monogenic diabetes decreases protein stability.
Szabó JE; Nyíri K; Andrási D; Matejka J; Ozohanics O; Vértessy B
Sci Rep; 2021 Sep; 11(1):19197. PubMed ID: 34584184
[TBL] [Abstract][Full Text] [Related]
13. An Update on the Potential Roles of E2F Family Members in Colorectal Cancer.
Xu Z; Qu H; Ren Y; Gong Z; Ri HJ; Chen X
Cancer Manag Res; 2021; 13():5509-5521. PubMed ID: 34276228
[TBL] [Abstract][Full Text] [Related]
14. Comparative Study of the Mode of Action of Clinically Approved Platinum-Based Chemotherapeutics.
Schoch S; Gajewski S; Rothfuß J; Hartwig A; Köberle B
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32967255
[TBL] [Abstract][Full Text] [Related]
15. The evolution of surgical treatment for gastrointestinal cancers.
Maehara Y; Soejima Y; Yoshizumi T; Kawahara N; Oki E; Saeki H; Akahoshi T; Ikegami T; Yamashita YI; Furuyama T; Sugimachi K; Harada N; Tagawa T; Harimoto N; Itoh S; Sonoda H; Ando K; Nakashima Y; Nagao Y; Yamashita N; Kasagi Y; Yukaya T; Kurihara T; Tsutsumi R; Takamori S; Sasaki S; Ikeda T; Yonemitsu Y; Fukuhara T; Kitao H; Iimori M; Kataoka Y; Wakasa T; Suzuki M; Teraishi K; Yoshida Y; Mori M
Int J Clin Oncol; 2019 Nov; 24(11):1333-1349. PubMed ID: 31522313
[TBL] [Abstract][Full Text] [Related]
16. Impact of primary tumor location as a predictive factor in patients suffering from colorectal cancer treated with cytotoxic anticancer agents based on the collagen gel droplet-embedded drug sensitivity test.
Ochiai T; Nishimura K; Watanabe T; Kitajima M; Nakatani A; Nagayasu K; Sakuyama N; Sato T; Kishine K; Abe Y; Nagaoka I
Oncol Lett; 2019 Feb; 17(2):1842-1850. PubMed ID: 30675246
[TBL] [Abstract][Full Text] [Related]
17. Interactions between anticancer active platinum complexes and non-coding RNAs/microRNAs.
Biersack B
Noncoding RNA Res; 2017 Mar; 2(1):1-17. PubMed ID: 30159416
[TBL] [Abstract][Full Text] [Related]
18. DNA replication stress and cancer chemotherapy.
Kitao H; Iimori M; Kataoka Y; Wakasa T; Tokunaga E; Saeki H; Oki E; Maehara Y
Cancer Sci; 2018 Feb; 109(2):264-271. PubMed ID: 29168596
[TBL] [Abstract][Full Text] [Related]
19. Selecting lncRNAs in gastric cancer cells for directed therapy with bioactive peptides and chemotherapy drugs.
Han W; Xiao R; Zhang C; Suyila Q; Li X; Su X
Oncotarget; 2017 Oct; 8(49):86082-86097. PubMed ID: 29156779
[TBL] [Abstract][Full Text] [Related]
20. MiRNAs and E2F3: a complex network of reciprocal regulations in human cancers.
Gao Y; Feng B; Lu L; Han S; Chu X; Chen L; Wang R
Oncotarget; 2017 Sep; 8(36):60624-60639. PubMed ID: 28947999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
